DBV Technologies Priced, Nasdaq: DBVT
French biotech developing immunotherapy patches that treat food allergies.
Industry: Health Care
First Day Return: +5.8%
Industry: Health Care
DBVT
French biotech developing immunotherapy patches that treat food allergies.
| IPO Data | |
|---|---|
| IPO File Date | 09/23/2014 |
| Offer Price | $21.64 |
| Price Range $23.00 - $23.00 | |
| Offer Shares (mm) | 4.3 |
| Deal Size ($mm) | $93 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 10/21/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $93 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Bagneux, France |
| Founded | 2002 |
| Employees at IPO | 47 |
| Website www.dbv-technologies.com | |
IPO News for DBV Technologies
DBV Technologies (DBVT) Performance
